Literatur
- 1
Aiuti A, Cattaneo F, Galimberti S. et al .
Gene therapy for immunodeficiency due to
adenosine deaminase deficiency.
N Engl J Med.
2009;
360
447-458
- 2
Boztug K, Appaswamy G, Ashikov A. et al .
A syndrome with congenital neutropenia and
mutations in G6PC3.
N Engl J Med.
2009;
360
32-43
- 3
Craig T J, Levy R J, Wasserman R L. et al .
Efficacy of human C1 esterase
inhibitor concentrate compared with placebo in acute hereditary
angioedema attacks.
J Allergy Clin Immunol.
2009;
124
801-808
- 4
Duan Q L, Binkley K, Rouleau G A.
Genetic analysis of Factor XII and bradykinin catabolic enzymes
in a family with estrogen-dependent inherited angioedema.
J
Allergy Clin Immunol.
2009;
123
906-910
- 5
Glocker E O, Hennigs A, Nabavi M. et al .
A homozygous CARD9 mutation in a family with
susceptibility to fungal infections.
N Engl J Med.
2009;
361
1727-1735
- 6
Hentges F, Hilger C, Kohnen M, Gilson G.
Angioedema and estrogen-dependent
angioedema with activation of the contact system.
J Allergy
Clin Immunol.
2009;
123
262-264
- 7
Notarangelo L D, Fischer A. International Union of
Immunological Societies Expert Committee on Primary Immunodeficiencies .
Primary immunodeficiencies:
2009 update.
J Allergy Clin Immunol.
2009;
124
1161-1178
- 8
Lachmann H J, Kone-Paut I, Kuemmerle-Deschner J B. et al .
Use of canakinumab
in the cryopyrin-associated periodic syndrome.
N Engl
J Med.
2009;
360
2416-2425
- 9
Neven B, Leroy S, Decaluwe H. et al .
Long-term outcome after hematopoietic stem cell
transplantation of a single-center cohort of 90 patients with severe
combined immunodeficiency.
Blood.
2009;
113
4114-4124
- 10
Routes J M, Grossman W J, Verbsky J. et al .
Statewide newborn screening for severe
T-cell lymphopenia.
JAMA.
2009;
302
2465-2470
- 11
Stein S, Ott M G, Schultze-Strasser S. et al .
Genomic instability and
myelodysplasia with monosomy 7 consequent to EVI1 activation after
gene therapy for chronic granulomatous disease.
Nat Med.
2010;
16
198-204
- 12
Straathof K C, Rao K, Eyrich M. et al .
Haemopoietic stem-cell transplantation
with antibody-based minimal-intensity conditioning: a phase 1/2
study.
Lancet.
2009;
374
912-920
- 13 US Food and Drug Administration .FDA labelling information – Kalbitor (ecallantide).
FDA website [online]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125277lbl.pdf
- 14
Warnatz K, Salzer U, Rizzi M. et al .
B-cell activating factor receptor deficiency
is associated with an adult-onset antibody deficiency syndrome in
humans.
Proc Natl Acad Sci U S A.
2009;
106
13945-13950
Prof. Dr. med. Georg Behrens
Klinik für Immunologie und Rheumatologie, Medizinische
Hochschule Hannover
Carl-Neuberg-Str. 1
30625
Hannover
Telefon: 0511/532-5713
Fax: 0511/532-5324
eMail: Behrens.georg@mh-hannover.de
